216 related articles for article (PubMed ID: 16330943)
1. Morphological evidence of an activated cytotoxic T-cell infiltrate in EBV-positive gastric carcinoma preventing lymph node metastases.
van Beek J; zur Hausen A; Snel SN; Berkhof J; Kranenbarg EK; van de Velde CJ; van den Brule AJ; Middeldorp JM; Meijer CJ; Bloemena E
Am J Surg Pathol; 2006 Jan; 30(1):59-65. PubMed ID: 16330943
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus positivity, not mismatch repair-deficiency, is a favorable risk factor for lymph node metastasis in submucosa-invasive early gastric cancer.
Park JH; Kim EK; Kim YH; Kim JH; Bae YS; Lee YC; Cheong JH; Noh SH; Kim H
Gastric Cancer; 2016 Oct; 19(4):1041-1051. PubMed ID: 26573601
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of Epstein-Barr virus-associated gastric cancer: a study of 235 cases at a comprehensive cancer center in U.S.A.
Truong CD; Feng W; Li W; Khoury T; Li Q; Alrawi S; Yu Y; Xie K; Yao J; Tan D
J Exp Clin Cancer Res; 2009 Feb; 28(1):14. PubMed ID: 19192297
[TBL] [Abstract][Full Text] [Related]
4. Intratumour T cells, their activation status and survival in gastric carcinomas characterised for microsatellite instability and Epstein-Barr virus infection.
Chiaravalli AM; Feltri M; Bertolini V; Bagnoli E; Furlan D; Cerutti R; Novario R; Capella C
Virchows Arch; 2006 Mar; 448(3):344-53. PubMed ID: 16261379
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus positivity among surgically resected intramucosal gastric cancer.
Murai K; Kakushima N; Sugino T; Yoshida M; Kawata N; Tanaka M; Takizawa K; Muramatu K; Kusafuka K; Bando E; Ono H
Dig Endosc; 2018 Sep; 30(5):667-671. PubMed ID: 29729036
[TBL] [Abstract][Full Text] [Related]
6. Increased frequency of antigen-specific CD8(+) cytotoxic T lymphocytes infiltrating an Epstein-Barr virus-associated gastric carcinoma.
Kuzushima K; Nakamura S; Nakamura T; Yamamura Y; Yokoyama N; Fujita M; Kiyono T; Tsurumi T
J Clin Invest; 1999 Jul; 104(2):163-71. PubMed ID: 10411545
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus-associated gastric carcinoma in Cali, Colombia.
Carrascal E; Koriyama C; Akiba S; Tamayo O; Itoh T; Eizuru Y; Garcia F; Sera M; Carrasquilla G; Piazuelo MB; Florez L; Bravo JC
Oncol Rep; 2003; 10(4):1059-62. PubMed ID: 12792770
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological and prognostic features of Epstein-Barr virus infection, microsatellite instability, and PD-L1 expression in gastric cancer.
Pereira MA; Ramos MFKP; Faraj SF; Dias AR; Yagi OK; Zilberstein B; Cecconello I; Alves VAF; de Mello ES; Ribeiro U
J Surg Oncol; 2018 Apr; 117(5):829-839. PubMed ID: 29534305
[TBL] [Abstract][Full Text] [Related]
9. The implication of tumor-infiltrating lymphocytes in Epstein-Barr virus-associated gastric carcinoma.
Gong LP; Chen JN; Xiao L; He Q; Feng ZY; Zhang ZG; Liu JP; Wei HB; Shao CK
Hum Pathol; 2019 Mar; 85():82-91. PubMed ID: 30448221
[TBL] [Abstract][Full Text] [Related]
10. The comparison of the prognosis between Epstein-Barr virus (EBV)-positive gastric carcinomas and EBV-negative ones.
Kijima Y; Ishigami S; Hokita S; Koriyama C; Akiba S; Eizuru Y; Aikou T
Cancer Lett; 2003 Oct; 200(1):33-40. PubMed ID: 14550950
[TBL] [Abstract][Full Text] [Related]
11. EBV-positive gastric adenocarcinomas: a distinct clinicopathologic entity with a low frequency of lymph node involvement.
van Beek J; zur Hausen A; Klein Kranenbarg E; van de Velde CJ; Middeldorp JM; van den Brule AJ; Meijer CJ; Bloemena E
J Clin Oncol; 2004 Feb; 22(4):664-70. PubMed ID: 14966089
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of tumor-infiltrating lymphocytes in Epstein-Barr virus-associated gastric cancer.
Kang BW; Seo AN; Yoon S; Bae HI; Jeon SW; Kwon OK; Chung HY; Yu W; Kang H; Kim JG
Ann Oncol; 2016 Mar; 27(3):494-501. PubMed ID: 26673353
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus-associated gastric cancer reveals intratumoral heterogeneity of PIK3CA mutations.
Böger C; Krüger S; Behrens HM; Bock S; Haag J; Kalthoff H; Röcken C
Ann Oncol; 2017 May; 28(5):1005-1014. PubMed ID: 28453696
[TBL] [Abstract][Full Text] [Related]
14. CD47 expression in Epstein-Barr virus-associated gastric carcinoma: coexistence with tumor immunity lowering the ratio of CD8
Abe H; Saito R; Ichimura T; Iwasaki A; Yamazawa S; Shinozaki-Ushiku A; Morikawa T; Ushiku T; Yamashita H; Seto Y; Fukayama M
Virchows Arch; 2018 Apr; 472(4):643-651. PubMed ID: 29536167
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic characteristics of Epstein-Barr virus-incorporated gastric cancers in Korea.
Chang MS; Lee HS; Kim CW; Kim YI; Kim WH
Pathol Res Pract; 2001; 197(6):395-400. PubMed ID: 11432666
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus infection serves as an independent predictor of survival in patients with lymphoepithelioma-like gastric carcinoma.
Min BH; Tae CH; Ahn SM; Kang SY; Woo SY; Kim S; Kim KM
Gastric Cancer; 2016 Jul; 19(3):852-9. PubMed ID: 26265391
[TBL] [Abstract][Full Text] [Related]
17. Relationship between Fas-ligand expression on carcinoma cell and cytotoxic T-lymphocyte response in lymphoepithelioma-like cancer of the stomach.
Kume T; Oshima K; Yamashita Y; Shirakusa T; Kikuchi M
Int J Cancer; 1999 Aug; 84(4):339-43. PubMed ID: 10404082
[TBL] [Abstract][Full Text] [Related]
18. Poor prognosis in Epstein-Barr virus-negative gastric cancer with lymphoid stroma is associated with immune phenotype.
Cho CJ; Kang HJ; Ryu YM; Park YS; Jeong HJ; Park YM; Lim H; Lee JH; Song HJ; Jung HY; Kim SY; Myung SJ
Gastric Cancer; 2018 Nov; 21(6):925-935. PubMed ID: 29627937
[TBL] [Abstract][Full Text] [Related]
19. High prevalence of Epstein-Barr virus in gastric remnant carcinoma after Billroth-II reconstruction.
Nishikawa J; Yanai H; Hirano A; Okamoto T; Nakamura H; Matsusaki K; Kawano T; Miura O; Okita K
Scand J Gastroenterol; 2002 Jul; 37(7):825-9. PubMed ID: 12190097
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and characteristics of Epstein-Barr virus-associated gastric carcinomas in Tunisia.
Trimeche M; Ksiâa F; Ziadi S; Mestiri S; Hachana M; Gacem RB; Sriha B; Korbi S
Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):1001-7. PubMed ID: 19491698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]